Cytokines as potential biomarkers for distinguishing patients with pancreatic cancer and type 2 diabetes mellitus

Pancreatology ◽  
2017 ◽  
Vol 17 (3) ◽  
pp. S33
Author(s):  
Rohith Gopala Rao ◽  
Lucy Oldfield ◽  
Anthony Evans ◽  
Lavanya Sivapalan ◽  
Philip Schuler ◽  
...  
2018 ◽  
Vol 9 (24) ◽  
pp. 4736-4741 ◽  
Author(s):  
Takuma Yoshinaga ◽  
Tatsuyuki Niou ◽  
Toru Niihara ◽  
Yoriko Kajiya ◽  
Emiko Hori ◽  
...  

2021 ◽  
Vol 11 ◽  
Author(s):  
Xiaoye Duan ◽  
Weihao Wang ◽  
Qi Pan ◽  
Lixin Guo

The relationship between type 2 diabetes mellitus (T2DM) and pancreatic cancer (PC) is complex. Diabetes is a known risk factor for PC, and new-onset diabetes (NOD) could be an early manifestation of PC that may be facilitate the early diagnosis of PC. Metformin offers a clear benefit of inhibiting PC, whereas insulin therapy may increase the risk of PC development. No evidence has shown that novel hypoglycemic drugs help or prevent PC. In this review, the effects of T2DM on PC development are summarized, and novel strategies for the prevention and treatment of T2DM and PC are discussed.


2021 ◽  
Vol 5 (1) ◽  
pp. 17-21
Author(s):  
Ayşegül SAKİN ◽  
Suleyman SAHİN ◽  
Abdullah SAKİN ◽  
Muhammed ATCİ ◽  
Çağlayan GEREDELİ ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document